BioClinica (BIOC) Stock Research, Analysis & News

Quick Analysis on BioClinica (BIOC) Stock as of August 20, 2017

Previous Closing Price $1.21 is below its 50 day moving average $1.38
Previous Closing Price $1.21 is below its 200 day moving average $1.67
The Price/Earnings To Growth ratio (PEG) is less than 1
The Stock pays no dividend
The closing price $1.21 is more than 100.83% away from its one year target price of $2.43
Current Short Ratio 14.97 is great than 1
Earning per Share $-1.06 is negative. BioClinica is lossing money.
EBITDA $-18.19M is negative
It is a very small cap stock with market cap of $36.30M
(See more information about BioClinica (BIOC) Stock below)

BioClinica (BIOC) Stock Profile Summary

BioClinica, Inc. provides integrated clinical research services. Its services include imaging core lab and eClinical technologies, and services for pharmaceutical, biotechnology, and medical device companies, as well as for other organizations, such as contract research organizations that engage in global clinical studies. The companys products and services include medical image management, electronic data capture, clinical data management, interactive voice and Web response, clinical trial supply forecasting tools, and electronic image transport and archive solutions. In addition, it provides enterprise software and hosted solutions. The companys eClinical solutions help pharmaceutical and biotech companies to collect, clean, process, and store data generated in clinical trials; and its Imaging Core Laboratory services support the collection and processing of clinical data primarily related to medical images, as well as helps clients with the design and management of the medical imaging component of clinical trials, and with the analysis and regulatory submission. It offers electronic image transport solutions to facilitate the blinding, sharing, tracking, and archiving of medical images for multi-center clinical trials. BioClinica operates two FDA-compliant core labs in the United States and Europe. The company was formerly known as Bio-Imaging Technologies, Inc. and changed its name to BioClinica, Inc. in July 2009. BioClinica was founded in 1987 and is headquartered in Newtown, Pennsylvania with business offices in the United States, France, Germany, the United Kingdom, and the Netherlands.

BioClinica (BIOC) Stock Key Statistics Research and Analysis as of August 20, 2017

Stock ExchangeNCM
Market Capitalization$36.30M
Trade Volume (Average Trading Volume)173,933 (506,627)
Price/Sales6.91
Price/Book4.73
Earning/Share$-1.06
Current Year EPS Estimate$-0.79
Next Year EPS Estimate$-0.66
Previous Closing Price$1.21
50 Day Price Moving Average$1.38
200 Day Price Moving Average$1.67
1 yr Target Price$2.43
PEG Ratio-0.04
Short Ratio14.97
EBITDA$-18.19M

BioClinica (BIOC) Stock Competitor Research and Analysis

eResearchTechnology, Inc. (ERES)Pharmaceutical Product Development Inc. (PPDI)

Latest Market News on BioClinica (BIOC)


Click here to find the latest news on BioClinica (BIOC)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

eResearchTechnology, Inc. (ERES)
Pharmaceutical Product Development Inc. (PPDI)